The debate about treating "low T" in older men is heating up

May 2014

Please see the March 2015 FDA notice concerning the possible increased risk of heart attack/stroke associated with testosterone use.

The debate about treating "low T" in older men is heating up...due to controversy over testosterone's cardiovascular risk.

A recent JAMA study has FDA investigating a possible link between testosterone therapy and heart attacks and strokes.

Critics say the JAMA study is flawed.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote